Gene · 25913
NIH grants1,830
NIH grants whose papers are about the gene, through NIH's grant-paper links.
941 to 960 of 1,830
Download this page as JSON| Grant | Title | POT1 papers | Newest fiscal year |
|---|---|---|---|
| UL1TR001108 | Indiana Clinical and Translational Sciences Institute | 3 | 2017 |
| UM1CA167551 | Colon Cancer Family Registry Cohort | 3 | 2017 |
| K01DK098285 | Resolving the role of nicotine-mediated phosphorylation on pancreatic fibrosis | 2 | 2017 |
| K07CA181480 | Lung Cancer Prediction Models Incorporating Exome Data from Extreme Phenotypes | 2 | 2017 |
| K99CA197672 | Manipulating hTERT splicing in lung cancer cells. | 2 | 2017 |
| K99GM120386 | Analysis of the Molecular Mechanisms of Telomerase Recruitment to Telomeres and Telomerase Catalysis | 2 | 2017 |
| P01CA124570 | Genetic and Signaling Pathways in Epithelial Thyroid Cancer | 2 | 2017 |
| P41GM103311 | Resource for Biocomputing Visualization and Informatics | 2 | 2017 |
| R01ES015632 | Roles of the RecQ Helicases BLM and RECQ5 in Genome Maintenance | 2 | 2017 |
| R01GM085145 | Mechanism of heterochromatin assembly | 2 | 2017 |
| S10OD023680 | High-Performance Computer Cluster for Biomedical Research | 2 | 2017 |
| F99CA212435 | Molecular mechanisms of genome maintenance during DNA replication and repair | 1 | 2017 |
| F99CA212439 | The roles of telomerase and non-coding RNA in cancer | 1 | 2017 |
| G12MD007599 | Basic and Translational Research Center for Reducing Health Disparities | 1 | 2017 |
| I01BX003341 | Genetic Vulnerability for Sustained Multi-Substance Use in MVP | 1 | 2017 |
| K01HL118683 | DDAH As a Novel Target in Pulmonary Fibrosis | 1 | 2017 |
| K12HD043494 | Center for Molecular & Cellular Studies of Ped Disease | 1 | 2017 |
| K99CA208012 | Histone modifications regulating phenotype plasticity: Role of non-canonical Wnt signaling | 1 | 2017 |
| K99CA212290 | The origins of chromosome rearrangement in the cancer genome | 1 | 2017 |
| K99GM120457 | Novel tools to investigate local and global RNA conformations in the spliceosome | 1 | 2017 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25913/grants?page=48